Category: General

Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold futures in the April contract settled last Friday in New York at 1,191 an ounce while currently trading at 1,213 up over $20 for the trading week right near a 10 week high as I've been sitting on the sidelines in this commodity recommending bullish positions in silver and copper. Gold prices are still trading above their 20-day but below their 100-day moving average as the trend is mixed to higher in my opinion as the U.S dollar is still hovering right around the 100 level as I'm also recommending a short position in that currency at present. The monthly unemployment number was released this morning adding about 227,000 new jobs having very little impact on gold prices in today's trade. The next major level of resistance is yesterday's high around 1,227 and if that is broken, I think we could go back to around the 1,300 level right where we were before the Trump election as there is still room to run to the upside. Continue reading "Weekly Futures Recap With Mike Seery" →

Analysts Predicting a 58% Gain for this Leading Cannabis Biotech

Posted on by The INO.com Team

Analysis originally distributed on January 25, 2017 By: Michael Vodicka of Cannabis Stock Trades

The cannabis industry is loaded with dozens of biotechs.

For example, if you take a look at the North American cannabis sector, you’ll see that the field is littered with biotechs such as Axim Biotechnologies (OTC:AXIM), Cara Therapeutics (Nasdaq:CARA) and Insys Therapeutics (Nasdaq:INSY).

These companies are aggressively searching for a cannabis-based medicine to treat some of the worst diseases plaguing humankind, including cancer, epilepsy, and HIV.

It’s obvious the cannabis industry sees a big opportunity in pharmaceuticals and is investing billions in research and development to cash in.

On the one hand, it’s great that investors have so many cannabis biotechs to choose from.

On the other, investing in biotech stocks is already one of the hardest sectors to pick winners and losers.

It’s even harder in the cannabis sector.

Some of these early cannabis biotechs will go on to make billions on blockbuster drugs and deliver market-crushing returns to shareholders.

Others will crumble and file for bankruptcy.

Today, I want to share my #1 cannabis biotech stock that I believe is ready to soar in 2017. Continue reading "Analysts Predicting a 58% Gain for this Leading Cannabis Biotech" →

Are 'Value' ETFs Worth The Risk?

Posted on by The INO.com Team

By: Richard Robinson of Street Authority

"Where are the customers' yachts?"

It was a question the tour guide didn't expect. He was taking a group of tourists through the financial district in lower Manhattan from the area now known as Battery Park.

Eventually docks appeared around the park. And because of its proximity to Wall Street, it became a favored location for Wall Street bankers and brokers to dock their very expensive yachts.

So it was on this day that the tour guide was extolling the virtues of Wall Street moneymen. He told his audience that the yachts were the rewards for creating enormous wealth for their customers.

To which one lone voice asked, "Where are the customers' yachts?" Continue reading "Are 'Value' ETFs Worth The Risk?" →

Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Mexican Peso Futures

The Mexican Peso in the March contract settled last Friday at 4594 while currently trading at 4730 hitting a 3 week high and if you have been following my previous blogs I've talked about this recently as prices hit all-time lows just a couple of weeks back against the U.S dollar as I think prices are just getting way overdone to the downside which is all based on the Trump administration being negative towards Mexico. The Peso is now trading above its 20-day moving average for the first time in months, but still below their 100-day as the short-term trend is mixed as I will wait for the 4 week high before entering into a bullish position as the chart structure will start to improve on a daily basis, therefore, lowering the monetary risk. I've been keeping a close eye on the U.S dollar for a short position, but it remains resilient still trading at about 100.50 as higher interest rates in the United States continue to support the U.S dollar. The next major level of resistance in the Peso is 4800, and if that is broken, you have to think that the multi-year bearish trend has finished.
TREND: MIXED
CHART STRUCTURE: SOLID

Continue reading "Weekly Futures Recap With Mike Seery" →

U.S. Economic Growth Slows To 1.9% In Fourth Quarter

Posted on by The INO.com Team

Hello MarketClub members everywhere. U.S. economic growth slowed more than expected last quarter on the biggest drag from trade in six years and more moderate consumer spending. However, business investment did pick up, which may be a sign that we can expect faster expansion in 2017.

MarketClub's Mid-day Market Report

The gross domestic product (GDP), rose only 1.9 percent in the 4th quarter on the heels of the 3rd quarter's 3.5 percent gain which happened to be the largest increase in two years. The reading fell short of expectations of economists surveyed by Bloomberg News, who had forecast a 2.2 percent annualized growth in the period. Consumer spending, the biggest part of the economy, climbed 2.5 percent, in line with projections.

The results capped growth at 1.6 percent for the full year (2016) and reinforce the leading role of household purchases while showing that businesses are starting to spend again. The strong job market and optimism among consumers and companies for President Donald Trump's policies are likely to keep growth humming along in 2017, though tensions over trade could temper any gains.

Key levels to watch next week: Continue reading "U.S. Economic Growth Slows To 1.9% In Fourth Quarter" →